SCA
KYNB

Secor Capital Advisors’s Kyntra Bio KYNB Stock Holding History

Secor Capital Advisors’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,430
Closed -$881K – 504
2017
Q1 		$881K Sell
1,430
-1,288
-47% -$784K 0.1% 259
2016
Q4 		$1.45M Buy
+2,718
New +$1.36M 0.18% 175
2016
Q3 		– Sell
-4,042
Closed -$1.66M – 564
2016
Q2 		$1.66M Buy
+4,042
New +$1.85M 0.21% 149

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Secor Capital Advisors's KYNB Position: Q2 2017 in Review

Secor Capital Advisors sold out of Kyntra Bio (KYNB) in Q2 2017, closing a stake of 1,430 shares — an estimated $881K sold.

Secor Capital Advisors first reported a position in KYNB in Q2 2016 and held it in 3 quarters. The position peaked at $1.66M in Q2 2016. 151 funds tracked by Wall St. Rank hold KYNB as of Q2 2017.

  • Secor Capital Advisors reported no remaining Kyntra Bio position as of Q2 2017 after selling out during the quarter.
  • Secor Capital Advisors sold 1,430 Kyntra Bio shares in Q2 2017, an estimated $881K.
  • Secor Capital Advisors first reported a position in Kyntra Bio in Q2 2016 and held it in 3 quarters.
  • Secor Capital Advisors's Kyntra Bio position peaked at $1.66M in Q2 2016.
  • 151 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2017.

Based on Secor Capital Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.